UK: Matt Hancock MP hosts UK Governments daily coronavirus briefing, Part Six.

The video discusses the discovery and support of promising vaccine projects, highlighting the Imperial vaccine's progress to human trials and Astra Zeneca's manufacturing deal for the Oxford vaccine. It emphasizes the strategy of manufacturing vaccines ahead of approval to ensure readiness, similar to the approach taken with dexamethasone. Additionally, it outlines the proposed prioritization plan for vaccine access once available.

What is the current phase of the Imperial vaccine in clinical trials?

Why is Astra Zeneca starting the manufacturing of the Oxford vaccine ahead of approval?

What is the significance of building a stockpile of the vaccine?

What was the approach taken with dexamethasone before it was proven clinically effective?

What strategy is being proposed for prioritizing access to the vaccine?